Brucellosis as a rare cause of granulomatous hepatitis with hepatic and bone marrow granulomas: A case report.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 137, doi. 10.14744/hf.2021.2021.0038
- By:
- Publication type:
- Article
Works matching IS 13075888 AND DT 2021 AND VI 2 AND IP 3
Results: 11
1
2
The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver disease.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 128, doi. 10.14744/hf.2021.2021.0037
- By:
- Publication type:
- Article
3
Sustainability of diet-based moderate calorie restriction among obese patients with metabolic-associated fatty liver disease.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 97, doi. 10.14744/hf.2021.2021.0014
- By:
- Publication type:
- Article
4
An overview of SARS-COV-2-related hepatic injury.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 122, doi. 10.14744/hf.2021.2021.0020
- By:
- Publication type:
- Article
5
Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
6
De novo hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 117, doi. 10.14744/hf.2021.2021.0019
- By:
- Publication type:
- Article
7
A novel insight into the pathophysiology of autoimmune hepatitis: An immune activator mutation in the FLT3 receptor.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 112, doi. 10.14744/hf.2021.2021.0010
- By:
- Publication type:
- Article
8
An appointment lead time of more than two weeks is significantly associated with not presenting for a liver biopsy procedure.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 107, doi. 10.14744/hf.2021.2021.0032
- By:
- Publication type:
- Article
9
The effect of transarterial chemoembolization therapy on survival in patients with non-resectable hepatocellular carcinoma: Single-center study results.
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 102, doi. 10.14744/hf.2021.2021.0029
- By:
- Publication type:
- Article
10
Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?
- Published in:
- Hepatology Forum, 2021, v. 2, n. 3, p. 91, doi. 10.14744/hf.2021.2021.0027
- By:
- Publication type:
- Article
11
New therapeutic players on the horizon: Edible plant derived exosomes.
- Published in:
- 2021
- By:
- Publication type:
- Editorial